Journal ArticleEJHaem · December 2024
Myelomatous pleural effusion (MPE) is a rare, often treatment-resistant complication of multiple myeloma. Intrapleural bortezomib shows promise but lacks standardized dosing. We report a 62-year-old woman with MPE treated with 1.3 mg/m2 (2 mg) s ...
Full textCite
